Press Releases
-
IQVIA and Veeva Announce Long-term Clinical and Commercial Partnerships and Resolution of All Disputes
Aug 17, 2025
-
Upperton Pharma Solutions Advancing Oral Vaccines Delivery with Oxford’s Pandemic Sciences Institute
Upperton, UK-based CDMO (Contract, Development & Manufacturing Organisation) awarded VaxHub Sustainable Grant to advance oral vaccine delivery in partnership with the University of Oxford’s Pandemic Sciences Institute. The project, led by Professor Dame Sarah Gilbert at the University of Oxford’s Pandemic Sciences Institute, aims to induce mucosal immunity, improve vaccine stability, simplify distribution, and support self-administration. Richard Johnson, Chief Scientific Officer at Upperton said: "Oral vaccine delivery has the potential to transform global immunisation and pandemic response strategies, and this project is a significant step forward where we can apply our formulation development expertise”.
Aug 17, 2025
-
Syncell Announces Strategic Co-Marketing Agreement to Advance High-Resolution Spatial Proteomics
Syncell and Thermo Fisher Scientific are working together to bring a fully integrated, high-resolution spatial proteomics workflow to the market.
Aug 13, 2025
-
Panthera Biopartners secures investment from LDC to accelerate expansion
Aug 11, 2025
-
Advarra debuts Braid™ to unlock operational intelligence and workflow automation in clinical trials through AI
Powered by the industry’s largest set of digitized protocols and operational data, Braid enables smarter trial design and greater operational efficiency
Aug 11, 2025
-
CapeStart Expands Operations with New Office in Chennai to Support AI Center of Excellence
With goal of delivering reliable AI solutions for life sciences companies, CapeStart continues to build out GenAI expertise, services, and the MadeAi™ platform
Aug 10, 2025
-
Arcinova Appoints Christian Dowdeswell as New Managing Director
Aug 5, 2025
-
Global healthcare AI experts and former UK Health Minister back AI that detects healthcare-associated infections up to 72 hours earlier
Aug 5, 2025
-
VieCure Expands Community Oncology Care Network with Addition of Summit Cancer Centers
VieCure adds Summit Cancer Centers to community oncology care network
Aug 4, 2025
-
Advarra appoints Brian Hart as Chief Technology Officer
Former Covera Health CTO to lead technology and product strategy at Advarra, driving innovation in clinical research
Aug 3, 2025
-
Symbiosis Reaches Major Milestone with 1,000th Batch of Injectable Drug Product
Jul 30, 2025
-
Emerald Clinical Trials Confirms CEO Transition and Continuity Plan
Jul 29, 2025
-
MAGENTIQ EYE Secures Series A Investment Led by aMoon to Drive the Future of AI-Powered Gastroenterology
MAGENTIQ EYE Secures Series A Investment Led by aMoon to Drive the Future of AI-Powered Gastroenterology
Jul 29, 2025
-
Sygnature Discovery Completes Major Enhancement of High-Throughput Chemistry Facilities Following £1 Million Investment
Jul 24, 2025
-
MIT Deploys Openwater’s Open-LIFU to Advance Neuroscience Research
MIT’s Lincoln Laboratory is first to receive the latest version of the device, with the goal to use low-intensity focused ultrasound to support its research exploring conscious perception.
Jul 23, 2025
-
Hoosier Cancer Research Network Report Reveals Key Trends Shaping Investigator-Initiated Oncology Trials
Hoosier Cancer Research Network has released a new report, “Investigator-Initiated Oncology Trials: Trends, Challenges, and Opportunities,” that captures the experience and perspectives of more than 130 researchers across its nationwide network. The findings highlight key trends shaping investigator-initiated oncology research and the operational, institutional, and funding challenges researchers face in today’s environment.
Jul 23, 2025
-
START and Advarra Unite to Deliver Unmatched Speed, Quality, and Predictability for Early-Phase Oncology Trials
START enhances its global leadership by integrating Advarra’s advanced regulatory and technology solutions, creating a seamlessly connected site network to accelerate trials and relieve pressure on the oncology drug development ecosystem.
Jul 23, 2025
-
Abzena Appoints Geoffrey M. Glass as Chief Executive Officer
Jul 22, 2025
-
Uniphar Rebrands On Demand Business to Uniphar Global Sourcing, Strengthening Global Pharmaceutical Offering
Jul 16, 2025
-
Sharp's Emissions Reduction Targets Validated by Science Based Targets initiative
Jul 15, 2025






